A Tale of Two Tumors: Pediatric and Adult Medulloblastoma.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1095
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2012 AND VI 26 AND IP 11
Results: 21
1
2
Adult Medulloblastoma, From Spongioblastoma Cerebelli to the Present Day: A Review of Treatment and the Integration of Molecular Markers.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1083
- By:
- Publication type:
- Article
3
Important Advances in the Treatment of Breast Cancer.
- Published in:
- 2012
- Publication type:
- Interview
4
Consultations IN Ethics.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1120
- By:
- Publication type:
- Article
5
Study Shows Fat Tissue Influences Tumor Growth Despite Diet.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1078
- Publication type:
- Article
6
The War on Waste.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1109
- By:
- Publication type:
- Article
7
Cost of Cancer: There Is More to It Than Containing Chemotherapy Costs.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1116
- By:
- Publication type:
- Article
8
The Cost of Cancer Care: Part II.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1104
- By:
- Publication type:
- Article
9
Immunosuppression Due to Lymphoma, Organ Transplant Increases Risk of Melanoma.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1073
- Publication type:
- Article
10
Medulloblastoma: Molecular Classifications and Prognostic Associations.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1097
- By:
- Publication type:
- Article
11
Early-Stage Lung Cancer: Trial Compares Radiosurgery to Standard Surgery.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1072
- Publication type:
- Article
12
ESMO: Regorafenib Improved PFS for GIST in Post-lmatinib/Sunitinib Setting.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1072
- Publication type:
- Article
13
Chronic Lymphocytic Leukemia With Deletion 17p: Emerging Treatment Options.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1067
- By:
- Publication type:
- Article
14
CLL Therapy: The Increasing Importance of Predictive Markers.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1064
- By:
- Publication type:
- Article
15
Immunotherapeutic Approaches Have the Potential to Brighten the Future Not Only for Patients With del(17pl3.1), but for All CLL Patients.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1055
- By:
- Publication type:
- Article
16
Chronic Lymphocytic Leukemia With del(17p13.1): A Distinct Clinical Subtype Requiring Novel Treatment Approaches.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1044
- By:
- Publication type:
- Article
17
Molecular Targeting in Cancer Therapy: Can We Fulfill the Promise?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1040
- By:
- Publication type:
- Article
18
Targeted Therapy: A Sea Change in the Treatment of Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1035
- By:
- Publication type:
- Article
19
Targeted Therapy: Its Status and Promise in Selected Solid Tumors Part II: Impact on Selected Tumor Subsets, and Areas of Evolving Integration.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1021
- By:
- Publication type:
- Article
20
THE CHEERFUL ONCOLOGIST. How My Practice Died.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 11, p. 1019
- By:
- Publication type:
- Article
21
Long-Term Effects of Chemo on the Cognitive Function of Cancer Patients.
- Published in:
- 2012
- Publication type:
- Interview